H

Humana

Sells Medicare health plans and runs senior clinics

Value-Based Programs Lead - Medicaid

Full-TimeDeadline 12/22/26
$104k - $143k/yr+ Bonus incentive plan
Senior
Bachelor's, Master's
Remote in USA
RemoteUp to 10% travel for onsite meetings; occasional travel to Humana offices may be required. Must work Eastern Standard Time hours (8:00 a.m.–5:00 p.m.).
Business & StrategyBusiness Operations

About the job

Requirements
  • A bachelor's degree is required.
  • A minimum of 5 years of experience in managed care operations, provider reimbursement and analytics, and value-based care is required.
  • Expertise in value-based payment model design and strategy with specialty providers, including pay for performance, bundles, accountable care, and shared savings and risk models, is required.
  • Expertise in Medicare and/or Medicaid managed care is required.
  • Ability to understand and analyze financial, utilization, and performance data is required.
  • Ability to identify, structure, and solve complex business problems is required.
  • Experience operating in a matrixed environment is required.
  • Interpersonal, organizational, written, oral communication, and presentation skills are required, including experience writing and delivering presentations to members of the management team.
Responsibilities
  • Support successful value-based provider relationships, focusing on improving provider experience and achieving path-to-value goals.
  • Lead end-to-end operational support of specialty Medicaid value-based payment models in alignment with segment strategy and goals.
  • Develop innovative value-based payment models for provider types including behavioral health, maternity, specialists, and social determinants of health, creating glide paths to move providers from volume to value.
  • Align the scope of work with the roadmap for new value-based payment model development to ensure compliance with Medicaid contractual requirements and request for proposal commitments.
  • Analyze financial, utilization, and performance data to identify opportunities to improve quality and/or reduce total cost of care.
  • Create value-based payment strategies and model designs, including payment model logic, performance metrics and benchmarks, and financial terms aligned with segment goals.
  • Design and contribute to the development of provider reporting packages to help providers understand their overall and detailed performance.
  • Partner with the finance team to conduct impact analysis and modeling for new value-based payment models.
  • Collaborate with team members and matrixed teams to operationalize and roll out new value-based payment models; contribute to solutions for operational gaps.
  • Monitor value-based payment model performance key performance indicators to identify opportunities to enhance model design based on internal and external feedback and performance data.
  • Translate strategy into models that can be piloted and scaled across markets.
Desired Qualifications
  • A master's degree is preferred.
  • Expertise in value-based payment financial modeling and impact analysis is preferred.

About the company

Humana sells health insurance paid for by government programs, chiefly Medicare Advantage plans that private insurers run for Americans 65 and older in place of traditional Medicare. It ranks among the largest Medicare Advantage insurers in the country and also runs Medicaid plans for low-income families in several states. Its CenterWell business operates senior primary care clinics, a mail-order pharmacy and home health services, so many members get care from a company the insurer owns. Medicare and states pay Humana a set monthly amount per member, and it keeps the difference between those payments and members' medical costs. Humana was founded in 1961 as a nursing home company and is based in Louisville, Kentucky.

Company Size

10,001+

Company Stage

IPO

Headquarters

Louisville, Kentucky

Founded

1961

Get referred to Humana

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Enrollment is surging: in July 2026 Humana affirmed about 25% individual Medicare Advantage membership growth for 2026.
  • Owned clinics create clinical careers: CenterWell Senior Primary Care added 130,900 patients, up 27%, in early 2026.
  • Medicaid is widening: Illinois chose Humana in June 2026 to run Medicaid coverage statewide.

What critics are saying

  • Low quality scores cut Medicare bonuses: only 20% of Humana's members sat in 4-star or better plans for 2026.
  • The insurer is shrinking to save margins: about 600,000 Medicare Advantage members got plan-closure notices in October 2026.
  • Stock grants carry risk: in July 2026 Humana cut its 2026 GAAP earnings floor to $6.52 a share from $8.36.

What makes Humana unique

  • Military families are a second market: Humana runs the Pentagon's TRICARE health plan across 24 eastern states and Washington, DC.
  • Florida anchors the business: Humana's Medicare Advantage contracts there produced 14% of its 2025 revenue.
  • Medicaid is a quiet second insurer: Humana covers over 1.54 million low-income members across 11 states.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • Unlimited Paid Time Off
  • Paid Vacation
  • Paid Parental Leave
  • Short-term Disability
  • Long-term Disability
  • 401(k) Retirement Plan
  • 401(k) Company Match

Growth & Insights and Company News

Headcount

6 month growth

6%

1 year growth

6%

2 year growth

6%
Yahoo Finance
Oct 20th, 2026
UnitedHealth and Humana raise drug costs 30% as older Americans face pricier Medicare

US insurers including UnitedHealth and Humana are cutting benefits for older clients and raising prescription drug costs for 2027, weeks before the midterm elections. Both insurers scrapped hundreds of plans and tightened coverage as older voters began choosing their plans. UnitedHealth and Humana raised maximum out-of-pocket costs by 11% and 8% respectively, according to investment bank Leerink. Both raised prescription drug coverage costs by about 30%. The changes affect 35 million Americans on Medicare Advantage plans, and the two firms hold about 46% of that market. The changes should help insurers' profits. UnitedHealth's healthcare division operating margin rose to 3.3% from 2.1% a year earlier, and Humana's shares are up 57% this year.

Yahoo Finance
Oct 9th, 2026
Humana soars 15% as 95% of Medicare members join four-star plans, beating analyst expectations

Humana shares surged 15% after the insurer announced 95% of its Medicare Advantage members will be in plans rated four stars or higher for 2027, up from just 20% a year ago. The result significantly exceeded J.P. Morgan analysts' expectations of 60% to 70%. Plans with four-star ratings or higher qualify for government bonus payments worth billions across the industry. The industry average for 2027 stands at roughly 71%. However, these ratings will determine bonus payments for 2028, not 2027. The improved ratings are particularly significant given Humana's thin margins. The company's EBIT margin has declined from 4.3% in 2023 to 2.3% on a last-twelve-months basis. Meanwhile, competitors moved in the opposite direction. UnitedHealth's four-star share is estimated to fall to approximately 67% from 81%, whilst CVS Health's drops to around 70% from 84%. CVS shares declined roughly 3%.

Yahoo Finance
Sep 13th, 2026
US health insurers rebound as medical costs stabilise, analysts predict 16% earnings growth through 2030

The health insurance industry may have recovered from high medical costs, with analysts predicting strong growth through 2030. Morningstar forecasts 16% annual earnings per share growth for major insurers, above the industry's typical low-double-digit target. Health insurers are improving profitability by raising rates to cover increased medical utilisation. UnitedHealth Group reported over $5 billion in second-quarter net income, with its medical care ratio falling to 86.7% from 89.4% year-over-year. The outlook also improved for pharmacy benefit management operations at companies like UnitedHealth, CVS Health, and Cigna. Despite increased regulatory scrutiny, the "big three" PBMs maintain strong competitive positions. Third-quarter earnings reports next month should provide further clarity on the industry's financial health.

PR Newswire
Sep 2nd, 2026
Thyme Care raises $125M at $2B+ valuation to expand oncology care model

Thyme Care, a Nashville-based oncology company, has closed a Series E funding round of more than $125 million at a valuation exceeding $2 billion. Morgan Health led the round, with participation from CVS Health Ventures, Humana, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health. The company now serves over 10.5 million people across all 50 US states and manages more than $7 billion in oncology spend. Thyme Care reports it is profitable with positive free cash flow whilst delivering validated reductions of 5 to 10 per cent in total cost of care. Alongside the funding, Thyme Care is establishing Thyme Companies, a parent entity that will build a portfolio of independent oncology businesses addressing care barriers. Co-founder Robin Shah will serve as executive chairman of the new entity.

Associated Press
Aug 20th, 2026
Humana appoints Dr. Shantanu Nundy as chief medical officer to lead AI and digital care strategy

Humana has appointed Dr Shantanu Nundy as Chief Medical Officer, effective 31 August. Dr Nundy, a practicing physician and healthcare executive, will help shape the company's products, platforms, and use of AI whilst bringing clinical expertise to the enterprise. He most recently served as Executive Vice President of Care Delivery and Chief Health Officer at Accolade, a healthcare navigation company. Previously, he was Managing Director for Clinical Innovation at Evolent Health, driving value-based and digital care transformation across health systems. Dr Nundy will report to Jim Rechtin, Humana's President and CEO, and join the company's Enterprise Leadership Team. He continues to practice primary care and hospital medicine.